An unwell patient with Parkinson's disease: Hyperpyrexia syndrome in a heatwave
- PMID: 35965941
- PMCID: PMC9373140
- DOI: 10.1177/20542704221086162
An unwell patient with Parkinson's disease: Hyperpyrexia syndrome in a heatwave
Abstract
Hyperpyrexia syndrome in Parkinson's disease (PD) is a medical emergency requiring prompt action. This can be precipitated by numerous provoking factors, in particular withdrawal of dopaminergic medication. We report a case of a patient with PD presenting with confusion, dramatic worsening of PD symptoms and pyrexia in the context of a heatwave, potentially mediating its effect through dehydration and impaired medication absorption. Precipitous cooling and conversion of dopaminergic medication to a rotigotine patch due to drowsiness led to her rapid improvement. The possibility of infection was covered however no source of infection or evidence of inflammatory response was found, but remained an important differential. This case highlights the importance of recognising and managing hyperpyrexia syndrome in PD and the possibility of uncharacteristically hot weather being a cause.
Keywords: Parkinson’s disease; heatwave; hyperpyrexia.
© 2022 The Author(s).
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Parkinsonism-hyperpyrexia syndrome: A case report and review of literature.Indian J Psychiatry. 2018 Oct-Dec;60(4):499-503. doi: 10.4103/psychiatry.IndianJPsychiatry_113_18. Indian J Psychiatry. 2018. PMID: 30581218 Free PMC article.
-
Dyskinesia-hyperpyrexia syndrome in Parkinson's disease triggered by overdose of levodopa - a case report and literature review.Front Neurol. 2024 Jan 5;14:1323717. doi: 10.3389/fneur.2023.1323717. eCollection 2023. Front Neurol. 2024. PMID: 38249748 Free PMC article.
-
[Dyskinesia-hyperpyrexia syndrome in a patient with Parkinson's disease: a case report].Rinsho Shinkeigaku. 2015;55(3):182-4. doi: 10.5692/clinicalneurol.55.182. Rinsho Shinkeigaku. 2015. PMID: 25786757 Japanese.
-
Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome.Drugs Today (Barc). 2010 Jul;46(7):483-505. doi: 10.1358/dot.2010.46.7.1463530. Drugs Today (Barc). 2010. PMID: 20683503 Review.
-
Rotigotine Transdermal Patch: A Review in Parkinson's Disease.CNS Drugs. 2019 Jul;33(7):707-718. doi: 10.1007/s40263-019-00646-y. CNS Drugs. 2019. PMID: 31243728 Review.
References
-
- Mizuno Y, Takubo H, Mizuta E, Kuno S. Malignant syndrome in Parkinson’s disease: concept and review of the literature. Park. Relat. Disord 2003; 9: 3–9. - PubMed
-
- Gaig C, Martí MJ, Tolosa E, Gómez-Choco MJ, Amaro S. Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave [1]. J Neurol 2005; 252: 1116–1119. - PubMed
-
- Takubo H, Harada T, Hashimoto T, et al. A collaborative study on the malignant syndrome in Parkinson’s disease and related disorders. Park Relat Disord 2003; 9(Suppl 1): 31–41. - PubMed
-
- Newman EJ, Grosset DG, Kennedy PGE. The parkinsonism-hyperpyrexia syndrome. Neurocrit Care 2009; 10: 136–140. - PubMed
Publication types
LinkOut - more resources
Full Text Sources